| Gregory Retzinger, MD | |
|
231 Albert Sabin Way, Department Of Pathology, Cincinnati, OH 45267-0001 | |
| (513) 558-4500 | |
| (513) 558-2289 |
| Full Name | Gregory Retzinger |
|---|---|
| Gender | Male |
| Speciality | Pathology - Clinical Pathology/laboratory Medicine |
| Location | 231 Albert Sabin Way, Cincinnati, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053334755 | NPI | - | NPPES |
| 0919340 | Medicaid | OH | |
| 000000009068 | Other | OH | ANTHEM |
| 283990 | Other | OH | AMERIGROUP |
| 200000700A | Medicaid | IN | |
| 64937923 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0105X | Pathology - Clinical Pathology/laboratory Medicine | 35-06-4628-R (Ohio) | Primary |
| Entity Name | Northwestern Medical Faculty Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346235314 PECOS PAC ID: 4587576814 Enrollment ID: O20031105000541 |
News Archive
Primordial, a leading vendor of workflow applications for the medical imaging market, announced today the first two deployments of Primordial RealTime - a real-time Electronic Whiteboard and Operational Tracking Platform - at NYU Langone Medical Center in New York and Mission Hospital in Asheville, NC.
A team at Children's National Medical Center has found that external stimulation has an impact on the postnatal development of a specific region of the brain. Published in Nature Neuroscience, the study used sensory deprivation to look at the growth and collection of NG2-expressing oligodendrocyte progenitor cells (NG2 cells) in the sensory cortex of the brain.
The details regarding the validation of this new device are published in the latest issue of Scientific Reports.
Unigene Laboratories, Inc. and Tarsa Therapeutics, Inc. today announced that Unigene has licensed its Phase III oral calcitonin program to Tarsa, a new company formed by a syndicate of three venture capital funds specializing in the life sciences: MVM Life Science Partners, Quaker BioVentures and Novo A/S.
Grifols, S.A. and Talecris Biotherapeutics Holdings Corp. announced today that the U.S. Federal Trade Commission has accepted for public comment a Consent Agreement that outlines the conditions necessary for Grifols' acquisition of Talecris to proceed.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory Retzinger, MD 2830 Victory Pkwy, Cincinnati, OH 45206-1785 Ph: (513) 245-3617 | Gregory Retzinger, MD 231 Albert Sabin Way, Department Of Pathology, Cincinnati, OH 45267-0001 Ph: (513) 558-4500 |
News Archive
Primordial, a leading vendor of workflow applications for the medical imaging market, announced today the first two deployments of Primordial RealTime - a real-time Electronic Whiteboard and Operational Tracking Platform - at NYU Langone Medical Center in New York and Mission Hospital in Asheville, NC.
A team at Children's National Medical Center has found that external stimulation has an impact on the postnatal development of a specific region of the brain. Published in Nature Neuroscience, the study used sensory deprivation to look at the growth and collection of NG2-expressing oligodendrocyte progenitor cells (NG2 cells) in the sensory cortex of the brain.
The details regarding the validation of this new device are published in the latest issue of Scientific Reports.
Unigene Laboratories, Inc. and Tarsa Therapeutics, Inc. today announced that Unigene has licensed its Phase III oral calcitonin program to Tarsa, a new company formed by a syndicate of three venture capital funds specializing in the life sciences: MVM Life Science Partners, Quaker BioVentures and Novo A/S.
Grifols, S.A. and Talecris Biotherapeutics Holdings Corp. announced today that the U.S. Federal Trade Commission has accepted for public comment a Consent Agreement that outlines the conditions necessary for Grifols' acquisition of Talecris to proceed.
› Verified 2 days ago
Bruce G Storrs, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 375 Dixmyth Ave, Cincinnati, OH 45220 Phone: 513-872-1400 | |
Mei Liang, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 234 Goodman St, Lab Medicine Building, Cincinnati, OH 45219 Phone: 513-584-3834 Fax: 513-558-2289 | |
Parsa Hodjat, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 3333 Burnet Ave., Ml 1035, Cincinnati, OH 45229 Phone: 513-636-4261 Fax: 513-636-3924 | |
Ila N Mehta Iii, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 375 Dixmyth Ave, Cincinnati, OH 45220 Phone: 513-624-4337 | |
Jiang Wang, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 234 Goodman St, Cincinnati, OH 45219 Phone: 513-584-1000 Fax: 513-584-3778 | |
Dani S Zander, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 234 Goodman St, Cincinnati, OH 45219 Phone: 513-584-7284 Fax: 513-584-3807 |